PerHydrogen begins its first major funding round in Q4 2025 to build a state-of-the-art microbiology facility in Johannesburg. The plant is designed to produce a minimum of 14 million units annually and a catalogue of over 150 products—from Prepared Plate Media to bottled and tube media—serving the clinical, pharmaceutical, food, water, and industrial sectors across Southern Africa and the continent at large. We are committed to pandemic readiness and to ensuring that essential diagnostics are locally manufactured, reducing dependency on imports and strengthening Africa’s health security.